Western Blotting Market Evolution in Healthcare Industry with Advance Prospects and Worldwide Demand by 2027

Western blot is the major analytical tool to assess the molecular function in basic cell biology research, drug discovery and pathology. There have been significant improvement in the technical aspect of western blot which has led to improvement in efficiency, reproducibility, ease of use. For example, iBind Western Systems launched by ThermoFisher Scientific Corporation which is and automated western blot device which does not require continuous monitoring. Further the turnaround time is reduced compared to traditional method where it involves the various steps and four hours for final results. In iBind all the solution is required to be loaded rest all process is automated by sequential lateral flow technology (SLF) which does not require any electricity or batteries. The significant advantage provided by automated western blot system will contribute in the growth of the western blot market.

The major players operating in the western blotting market include:-

Thermo Fisher Scientific Inc., Merck KGaA, GENERAL ELECTRIC, Cell Signaling Technology, Inc., PerkinElmer, Inc., Bio-Rad Laboratories, Inc., LI-COR, Inc., OriGene Technologies, Inc., Rockland Immunochemicals Inc., and Abcam plc among the others.

Get Sample Copy of the Report at - https://www.theinsightpartners.com/sample/TIPHE100001121/

Key Elements that the report acknowledges:

- Market size and growth rate during forecast period.

- Key factors driving the “WESTERN BLOTTING” market.

- Key market trends cracking up the growth of the “WESTERN BLOTTING” market.

- Challenges to market growth.

- Key vendors of “WESTERN BLOTTING” market.

- Detailed SWOT analysis.

- Opportunities and threats faces by the existing vendors in Global “WESTERN BLOTTING” market.

- Trending factors influencing the market in the geographical regions.

- Strategic initiatives focusing the leading vendors.

- PEST analysis of the market in the five major regions.

Western blot delivers both confirmatory results in the field of research and diagnostic testing. Lyme is the tick-borne disease in the region of North America. According to study published in 2018, by Carnegie Mellon University sates that Lyme disease is expected to rise in United States. Reason for rise in Lyme disease is the climate change. Various studies have shown western blot IgM has 94-96% of specificity towards the patient with clinical symptom of Lyme disease. Western blot is used in the confirmatory test for HIV followed by ELISA test. Western blot was specifically gold standard for the diagnosis of HIV-1 infection. According to data published on the site of HIV.gov in 2016, approximately 38,700 people were newly infected by HIV. Therefore, owing to the above mentioned factors it is expected that the market is likely to grow during the forecast period.

Avail Discount on the Report at - https://www.theinsightpartners.com/discount/TIPHE100001121/

Asia Pacific is the fastest growing geographic market and it is expected to be the fastest revenue contributor throughout the forecast period. The market in the Asia Pacific is driven by the key factors such as rise in biotechnologies industry across the nations such as China, Japan, India and South Korea. The increasing investments in the sector is likely to encourage the growth of the market during the forecast period. In addition, the market is also expected to grow due to support of government that have initiated programs to increasing the professionals. The collaboration of the countries such China and Japan with the foreign entities are expected to grow the market during the forecast period. 

The report segments the global western blotting market as follows: 

Global Western Blotting Market – By Product

  • Instruments
    • Imagers
    • Gel Electrophoresis Instruments
    • Blotting Systems
  • Consumables
    • Kits
    • Reagents
    • Others 

Global Western Blotting Market – By Application

  • Biomedical & Biochemical Research
  • Agricultures
  • Others 

Global Western Blotting Market – By End User

  • Biotechnological & Pharmaceutical Companies
  • Diagnostic Laboratories
  • Academic & Research Institutes
  • Others

Strategic Insights

Organic and inorganic growth strategies were observed among which organic strategy was the most adopted strategy in global western blotting industry. For instance, in June, 2019. Thermo Fisher Scientific Inc. launched iBright 1500 Imaging System Series that includes two models, the Invitrogen iBright FL1500 imaging system and the Invitrogen iBright CL1500 imaging system for life science researchers. Thus, various product launch in the market are likely to influence the market growth during forecast period.

Purchase this report at - https://www.theinsightpartners.com/buy/TIPHE100001121/


 - Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Global Western Blotting Market.

- Highlights key business priorities in order to assist companies to realign their business strategies.

- The key findings and recommendations highlight crucial progressive industry trends in the Western Blotting, thereby allowing players to develop effective long term strategies.

- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.

About Us: 

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense. 

Contact Us: 

Call: +1-646-491-9876

Email: [email protected]

Website: www.theinsightpartners.com/      

Posted by on Monday July 22 2019, 2:16 PM EDT. All trademarks acknowledged. Filed under Biotechnology, Diagnostics, Healthcare, Life Sciences, Medical Devices, Pharmaceuticals. Comments and Trackbacks closed. Follow responses: RSS 2.0

Comments are closed

News Categories

Featured Press Releases

Log in